Why is Nath Bio-Genes falling/rising?

As of 23-Jul, Nath Bio-Genes (India) Ltd is currently priced at 191.00, reflecting an increase of 1.0 (0.53%). The stock has shown a trend reversal, gaining after two consecutive days of decline. However, it has underperformed the sector by 4.02% over the past week and 3.17% over the past month. Despite today's positive movement, the stock's performance over the last year has been poor, with a return of -20.42%. The company has a low Return on Equity (ROE) of 6, indicating weak profitability, and its operating profits have experienced a -0.69% CAGR growth over the last five years. While the stock is trading at a discount compared to its peers, the overall weak long-term fundamentals and consistent underperformance against the benchmark raise concerns.
In the broader market context, the Sensex has shown a slight increase of 0.11% over the past week and 1.01% over the past month, contrasting with Nath Bio-Genes' negative returns during the same periods. The stock's liquidity is adequate for trading, but a significant drop in delivery volume suggests falling investor participation, which could further impact its price movement. Overall, while there are some attractive valuation metrics, the persistent underperformance and weak fundamentals indicate that the stock may struggle to gain traction in the current market environment.